Simcere Pharmaceutical
Simcere is a Chinese pharmaceutical company dedicated to research & development of innovative pharmaceuticals and branded generic drugs in China.
The company focuses its efforts on the therapeutic areas of oncology, neurology, inflammation/immunology, cardiovascular and infectious diseases.
In September 2017, it was announced that Simcere had signed a deal with US biotech major Amgen for the development of biosimilars for the Chinese market.
Latest Simcere Pharmaceutical News & Features
25 September 2023
20 February 2023
16 November 2022
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze